SHERRI BRIDGES: Open Payments
NPI 1982975827 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 44 payments from 14 companies in 2025. Trend: 2023 $915 · 2024 $696 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| Lilly USA, LLC | 9 | $163 |
| PFIZER INC. | 5 | $101 |
| Corcept Therapeutics | 3 | $101 |
| Novo Nordisk Inc | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Abbott Laboratories | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: FARXIGA, JARDIANCE, Korlym, PREVNAR 20, MOUNJARO, Kerendia, FREESTYLE LIBRE 3, Ozempic.
Industry payments across TX — which companies pay providers there.
